Company news

Indivior Pharmaceuticals, Inc. news in 2023

Indivior Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Indivior Announces Q3 2023 Financial Results

November 8, 2023

Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals

October 10, 2023

Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in Canada

September 25, 2023

Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims

August 20, 2023

Indivior Announces Q2/H1 2023 Financial Results

July 26, 2023

Indivior Announces Four Abstracts Accepted for Presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence

June 13, 2023

Calls in 2023

Decks in 2023